COL1A1 and osteoporosis: Our Col1a1-NO66 transgenic mice constitute a new epigenetic animal model to study the chromatin alterations in the context of age-related osteoporosis, as well as a potential preclinical animal model for the evaluation of select novel drugs for the prevention and treatment of human osteoporosis.